6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Protein interaction screening identifies SH3RF1 as a new regulator of FAT1 protein levels.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mutations and ectopic FAT1 cadherin expression are implicated in a broad spectrum of diseases ranging from developmental disorders to cancer. The regulation of FAT1 and its downstream signalling pathways remain incompletely understood. We hypothesized that identification of additional proteins interacting with the FAT1 cytoplasmic tail would further delineate its regulation and function. A yeast two-hybrid library screen carried out against the juxtamembrane region of the cytoplasmic tail of FAT1 identified the E3 ubiquitin-protein ligase SH3RF1 as the most frequently recovered protein-binding partner. Ablating SH3RF1 using siRNA increased cellular FAT1 protein levels and stabilized expression at the cell surface, while overexpression of SH3RF1 reduced FAT1 levels. We conclude that SH3RF1 acts as a negative post-translational regulator of FAT1 levels.

          Related collections

          Author and article information

          Journal
          FEBS Lett.
          FEBS letters
          Wiley
          1873-3468
          0014-5793
          Feb 2017
          : 591
          : 4
          Affiliations
          [1 ] VIB Center for the Biology of Disease, Leuven, Belgium.
          [2 ] Hunter Cancer Research Alliance, University of Newcastle, Callaghan, Australia.
          [3 ] The Biomedical Research Centre, University of British Columbia, Vancouver, Canada.
          [4 ] School of Environmental and Life Sciences, University of Newcastle, Callaghan, Australia.
          [5 ] School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia.
          [6 ] The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Australia.
          Article
          10.1002/1873-3468.12569
          28129444
          dc100196-f0ef-4c3a-b650-127dfdc87130
          History

          SH3RF1,protein half-life,protein-protein interaction,yeast two-hybrid,E3 ubiquitin-ligase,FAT1 cadherin

          Comments

          Comment on this article